Related references
Note: Only part of the references are listed.Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung Cancer
Deli Hong et al.
CANCER RESEARCH (2022)
Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer
Hao Luo et al.
SEMINARS IN CANCER BIOLOGY (2022)
Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer
Yi Wang et al.
SEMINARS IN CANCER BIOLOGY (2022)
Evolving role of immunotherapy in small cell lung cancer
Elizabeth D. Barrows et al.
SEMINARS IN CANCER BIOLOGY (2022)
CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4
Peng Liao et al.
CANCER CELL (2022)
Neutrophil extracellular traps in cancer
Leonardo Cristinziano et al.
SEMINARS IN CANCER BIOLOGY (2022)
Ferroptosis: A Novel Mechanism of Artemisinin and its Derivatives in Cancer Therapy
Shunqin Zhu et al.
CURRENT MEDICINAL CHEMISTRY (2021)
NK cells and ILCs in tumor immunotherapy
Simona Sivori et al.
MOLECULAR ASPECTS OF MEDICINE (2021)
Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase
Qi Xiong et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Characterization of Tumor-Associated Macrophages and the Immune Microenvironment in Limited-Stage Neuroendocrine-High and -Low Small Cell Lung Cancer
David Dora et al.
BIOLOGY-BASEL (2021)
A decade of cell death studies: Breathing new life into necroptosis
Imran Khan et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
Pranavi Koppula et al.
PROTEIN & CELL (2021)
A Nanoplatform to Amplify Apoptosis-to-Pyroptosis Immunotherapy via Immunomodulation of Myeloid-Derived Suppressor Cells
Shiyao Zhou et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The multifaceted roles of gasdermins in cancer biology and oncologic therapies
David Sarrio et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis
Mingrui Zhu et al.
CANCER RESEARCH (2021)
Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma
Yinfei Tan et al.
CLINICAL CANCER RESEARCH (2021)
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer
Joseph M. Chan et al.
CANCER CELL (2021)
Effective ferroptotic small-cell lung cancer cell death from SLC7A11 inhibition by sulforaphane
Yuko Iida et al.
ONCOLOGY LETTERS (2021)
Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy
Sheera R. Rosenbaum et al.
CANCER DISCOVERY (2021)
Tumor-Infiltrating Natural Killer Cells
Beatriz Cozar et al.
CANCER DISCOVERY (2021)
Small Cell Lung Cancer, Version 2.2022
Apar Kishor P. Ganti et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Epigenetic silencing of chemokine CCL2 represses macrophage infiltration to potentiate tumor development in small cell lung cancer
Yang Zheng et al.
CANCER LETTERS (2021)
CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability
Xingzhe Ma et al.
CELL METABOLISM (2021)
Broadening horizons: the role of ferroptosis in cancer
Xin Chen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
Guohao Wang et al.
NATURE COMMUNICATIONS (2021)
Preoperative peripheral blood neutrophil-to-lymphocyte ratios (NLR) and platelet-to-lymphocyte ratio (PLR) related nomograms predict the survival of patients with limited-stage small-cell lung cancer
Chunji Chen et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer
Ling Cai et al.
COMMUNICATIONS BIOLOGY (2021)
Reframing recalcitrance for small-cell lung cancer
F. H. Blackhall
ANNALS OF ONCOLOGY (2021)
Identification of a prognostic immune-related signature for small cell lung cancer
Qi Xie et al.
CANCER MEDICINE (2021)
Microenvironment-Responsive Prodrug-Induced Pyroptosis Boosts Cancer Immunotherapy
Yao Xiao et al.
ADVANCED SCIENCE (2021)
Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment
Peixin Chen et al.
FRONTIERS IN ONCOLOGY (2021)
Pyroptosis: a new paradigm of cell death for fighting against cancer
Yixin Tan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Epithelial-Mesenchymal Transition Induces GSDME Transcriptional Activation for Inflammatory Pyroptosis
Chenqiang Jia et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLC
L. Portia Thomas et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Integrative analysis of multi-omics data reveals the heterogeneity and signatures of immune therapy for small cell lung cancer
Yabin Chen et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Role of iron in cancer
Konstantin Salnikow
SEMINARS IN CANCER BIOLOGY (2021)
Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes
Christina M. Bebber et al.
NATURE COMMUNICATIONS (2021)
FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-III
Minlin Jiang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin
Zheng Tang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11
Xinbo Wang et al.
CANCER RESEARCH (2021)
Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor Cells
Dwight H. Owen et al.
CLINICAL LUNG CANCER (2021)
Necroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulators
Jinho Seo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
High proportion of tumor necrosis predicts poor survival in surgically resected high-grade neuroendocrine carcinoma of the lung
Akira Sugimoto et al.
LUNG CANCER (2021)
RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment
Han-Hee Park et al.
MOLECULAR CANCER (2021)
Identifying and targeting the Achilles heel of a recalcitrant cancer
Triparna Sen
SCIENCE TRANSLATIONAL MEDICINE (2021)
Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer
Nitin Roper et al.
NATURE COMMUNICATIONS (2021)
iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4
Delin Chen et al.
NATURE COMMUNICATIONS (2021)
Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer
Huaqiang Zhou et al.
NATURE COMMUNICATIONS (2021)
Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I-III small cell lung cancer
Peixin Chen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Genetic alternations and immune characteristics in patients with small cell lung cancer
Chenyue Zhang et al.
CANCER COMMUNICATIONS (2021)
RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11
Wenjing Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Combination of DNA demethylation and chemotherapy to trigger cell pyroptosis for inhalation treatment of lung cancer
Beibei Xie et al.
NANOSCALE (2021)
An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment
Chih-Hsiung Hsieh et al.
THERANOSTICS (2021)
Advances in novel molecular typing and precise treatment strategies for small cell lung cancer
Rilan Bai et al.
CHINESE JOURNAL OF CANCER RESEARCH (2021)
Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment
Sheng-Kai Hsu et al.
THERANOSTICS (2021)
A nomogram to predict the overall survival of patients with symptomatic extensive-stage small cell lung cancer treated with thoracic radiotherapy
Xun Yuan et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Filippo Veglia et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Prognostic significance of OX40(+) lymphocytes in tumor stroma of surgically resected small-cell lung cancer
Hiroshi Yokouchi et al.
ONCOIMMUNOLOGY (2021)
Ferroptosis is a type of autophagy-dependent cell death
Borong Zhou et al.
SEMINARS IN CANCER BIOLOGY (2020)
Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis
Guo-Qing Chen et al.
CELL DEATH AND DIFFERENTIATION (2020)
Caspases in Cell Death, Inflammation, and Pyroptosis
Sannula Kesavardhana et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Inhibition of kras-derived exosomes downregulates immunosuppressive BACH2/GATA-3 expression via RIP-3 dependent necroptosis and miR-146/miR-210 modulation
Savvas Petanidis et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Myeloid-derived suppressor cells-new and exciting players in lung cancer
Zhenzhen Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
Yuying Liu et al.
SCIENCE IMMUNOLOGY (2020)
Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study
Charles M. Rudin et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis
Yan Lu et al.
PLOS ONE (2020)
Harnessing Natural Killer Immunity in Metastatic SCLC
Sarah A. Best et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Gasdermin E suppresses tumour growth by activating anti-tumour immunity
Zhibin Zhang et al.
NATURE (2020)
A bioorthogonal system reveals antitumour immune function of pyroptosis
Qinyang Wang et al.
NATURE (2020)
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li et al.
NUCLEIC ACIDS RESEARCH (2020)
SIRT3 increases cisplatin sensitivity of small-cell lung cancer through apoptosis
Rui Guo et al.
GENE (2020)
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Rong Tang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy
Pengfei Zhao et al.
BIOMATERIALS (2020)
PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis
Junwei Hou et al.
NATURE CELL BIOLOGY (2020)
CD39: the potential target in small cell lung cancer
Shanhao Chen et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Multiple modes of cell death in neuroendocrine tumors induced by artesunate
Ge Yan et al.
PHYTOMEDICINE (2020)
Pharmacotranscriptomic Analysis Reveals Novel Drugs and Gene Networks Regulating Ferroptosis in Cancer
Haitang Yang et al.
CANCERS (2020)
De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors
Samuel T. Workenhe et al.
COMMUNICATIONS BIOLOGY (2020)
Co-administration of sulforaphane and doxorubicin attenuates breast cancer growth by preventing the accumulation of myeloid-derived suppressor cells
Yuan Rong et al.
CANCER LETTERS (2020)
GSDME enhances Cisplatin sensitivity to regress non-small cell lung carcinoma by mediating pyroptosis to trigger antitumor immunocyte infiltration
Zhouyangfan Peng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Turning Cold into Hot: Firing up the Tumor Microenvironment
Qianqian Duan et al.
TRENDS IN CANCER (2020)
Recombinant viruses delivering the necroptosis mediator MLKL induce a potent antitumor immunity in mice
Lien Van Hoecke et al.
ONCOIMMUNOLOGY (2020)
PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer
Xiao Fu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Targeting Ferroptosis to Iron Out Cancer
Behrouz Hassannia et al.
CANCER CELL (2019)
Immune Cell Infiltration May Be a Key Determinant of Long-Term Survival in Small Cell Lung Cancer
Prasuna Muppa et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin Wang et al.
NATURE (2019)
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw et al.
CANCER RESEARCH (2019)
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity
Annelise G. Snyder et al.
SCIENCE IMMUNOLOGY (2019)
The role of pyroptosis in gastrointestinal cancer and immune responses to intestinal microbial infection
Cheng-Bei Zhou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
GSDMD is required for effector CD8+ T cell responses to lung cancer cells
Guangmin Xi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC
Triparna Sen et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
Xueting Lang et al.
CANCER DISCOVERY (2019)
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Luis Paz-Ares et al.
LANCET (2019)
Epigenetics-Based Tumor Cells Pyroptosis for Enhancing the Immunological Effect of Chemotherapeutic Nanocarriers
Jin-Xuan Fan et al.
NANO LETTERS (2019)
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Kirill Bersuker et al.
NATURE (2019)
Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer
Alberto A. Chiappori et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Plasmacytoid Dendritic Cells: Development, Regulation, and Function
Boris Reizis
IMMUNITY (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Charles M. Rudin et al.
NATURE REVIEWS CANCER (2019)
Mouse lung fibroblasts are highly susceptible to necroptosis in a reactive oxygen species-dependent manner
Muadh Hussain et al.
BIOCHEMICAL PHARMACOLOGY (2018)
NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model
Yan Liu et al.
CANCER RESEARCH (2018)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2018)
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes
L. Bonanno et al.
EUROPEAN JOURNAL OF CANCER (2018)
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
L. Horn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Necroptosis promotes autophagy-dependent upregulation of DAMP and results in immunosurveillance
Sheng-Yen Lin et al.
AUTOPHAGY (2018)
Nrf2 targeting by sulforaphane: A potential therapy for cancer treatment
Maria Russo et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2018)
Molecular Targeted Therapies Elicit Concurrent Apoptotic and GSDME-Dependent Pyroptotic Tumor Cell Death
Haijiao Lu et al.
CLINICAL CANCER RESEARCH (2018)
The cell-cell interaction between tumor-associated macrophages and small cell lung cancer cells is involved in tumor progression via STAT3 activation
Toyohisa Iriki et al.
LUNG CANCER (2017)
Small-cell lung cancer: what we know, what we need to know and the path forward
Adi F. Gazdar et al.
NATURE REVIEWS CANCER (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
Kipp Weiskopf et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)
Anna Sophie Berghoff et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Non-canonical programmed cell death mechanisms triggered by natural compounds
Marc Diederich et al.
SEMINARS IN CANCER BIOLOGY (2016)
Increased circulating CD14(+) HLA-DR-/low myeloid-derived suppressor cells are associated with poor prognosis in patients with small-cell lung cancer
Tian Tian et al.
CANCER BIOMARKERS (2015)
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Jianjin Shi et al.
NATURE (2015)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
Ferroptosis as a p53-mediated activity during tumour suppression
Le Jiang et al.
NATURE (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells
Nader Yatim et al.
SCIENCE (2015)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis
Zhenyu Cai et al.
NATURE CELL BIOLOGY (2014)
Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
Cristina Iclozan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
The x c - cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine
Jun Guan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Increased numbers of spontaneous SCLC metastasis in absence of NK cells after subcutaneous inoculation of different SCLC cell lines into pfp/rag2 double knock out mice
Stephan Sodeur et al.
CANCER LETTERS (2009)
The IASLC Lung Cancer Staging Project Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer
Eric Vallieres et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Reciprocal CD4+ T-Cell Balance of Effector CD62Llow CD4+ and CD62Lhigh CD25+ CD4+ Regulatory T Cells in Small Cell Lung Cancer Reflects Disease Stage
Kenichi Koyama et al.
CLINICAL CANCER RESEARCH (2008)
Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells
D Sadava et al.
CANCER LETTERS (2002)